Ajanta Pharma - Quarterly Results
29th Oct 2021

The September 2021 quarter revenue stood at Rs. 8237.10 millions, up 21.76% as compared to Rs. 6765.10 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -12.60% to Rs. 1968.50  millions from Rs. 2252.20 millions.A decline of 2852.60 millions was observed in the OP in the quarter ended September 2021 from 3370.80 millions on QoQ basis.



(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 8237.10 6765.10 21.76 15664.30 12373.60 26.59 27185.90 21964.20 23.77
Other Income 524.10 862.40 -39.23 834.10 993.40 -16.04 1035.70 1842.00 -43.77
PBIDT 2852.60 3370.80 -15.37 5492.80 5236.10 4.90 10204.80 7169.80 42.33
Interest 0.70 13.50 -94.81 12.40 25.50 -51.37 69.00 91.00 -24.18
PBDT 2851.90 3357.30 -15.05 5480.40 5210.60 5.18 10135.80 7039.60 43.98
Depreciation 304.00 272.00 11.76 601.60 540.60 11.28 1114.90 912.90 22.13
PBT 2547.90 3085.30 -17.42 4878.80 4670.00 4.47 9020.90 6126.70 47.24
TAX 579.40 833.10 -30.45 975.70 1260.90 -22.62 2264.50 1715.40 32.01
Deferred Tax 30.80 91.60 -66.38 63.40 138.70 -54.29 97.70 34.50 183.19
PAT 1968.50 2252.20 -12.60 3903.10 3409.10 14.49 6756.40 4411.30 53.16
Equity 173.90 175.40 -0.86 173.90 175.40 -0.86 173.90 175.40 -0.86
PBIDTM(%) 34.63 49.83 -30.50 35.07 42.32 -17.14 37.54 32.64 14.99